article thumbnail

Novo Nordisk to expand French production facilities

European Pharmaceutical Review

These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Recent European manufacturing investments Earlier this month, Novo Nordisk announced that it was planning another manufacturing facility expansion, this time at its site in Kalundborg, Denmark. Construction has already begun.

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

16th edition of CPHI & PMEC India Expo to be held from November 28-30, 2023, at India Expo Centre, Greater Noida

Express Pharma

lakh crores) by 2028. CPHI & PMEC India, along with its ancillary programmes, spotlights technological strides pivotal in propelling India’s pharma machinery, technology, and ingredients sectors. The Indian pharma industry, on the brink of significant expansion, eyes a projected CAGR of 13 per cent, eyeing a market value of $102.7

article thumbnail

Steriline to exhibit its Robotic Vial Filling Machine at ACHEMA 2024

Express Pharma

The market for pharmaceutical packaging will grow by 8.24 per cent worldwide and the market for pharmaceutical packaging machines by 7.5 per cent per year until 2028 1. in the EU).

Packaging 103
article thumbnail

Astellas breaks ground on new facility

European Pharmaceutical Review

The facility is planned to be operational by 2028, Astellas said. Today marks a significant achievement for our company and reflects our continued commitment to expansion and innovation in the region,” declared Hideki Shima, Chief Manufacturing Officer, Astellas Pharma.